Literature DB >> 21436437

Combining targeted drugs to stop resistant tumors.

Jocelyn Kaiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21436437     DOI： 10.1126/science.331.6024.1542

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  20 in total

1.  Simultaneous observation of the metabolism of cisplatin and NAMI-A in human plasma in vitro by SEC-ICP-AES.

Authors:  Melani Sooriyaarachchi; Jason L Wedding; Hugh H Harris; Jürgen Gailer
Journal:  J Biol Inorg Chem       Date:  2014-01-24       Impact factor: 3.358

2.  Phenylpropanoids from Phragmipedium calurum and their antiproliferative activity.

Authors:  Courtney M Starks; Russell B Williams; Vanessa L Norman; Julie A Lawrence; Mark O'Neil-Johnson; Gary R Eldridge
Journal:  Phytochemistry       Date:  2012-07-16       Impact factor: 4.072

3.  Finding a Panacea among combination cancer therapies.

Authors:  Ryuji Yamaguchi; Guy Perkins
Journal:  Cancer Res       Date:  2011-11-03       Impact factor: 12.701

4.  Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers.

Authors:  Ting Luo; Jianqing Yu; Jenny Nguyen; Chun-Rong Wang; Robert G Bristow; David A Jaffray; Xiao Zhen Zhou; Kun Ping Lu; Qing-Bin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

5.  MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.

Authors:  Chin-Tung Chen; Hyaehwan Kim; David Liska; Sizhi Gao; James G Christensen; Martin R Weiser
Journal:  Mol Cancer Ther       Date:  2012-01-11       Impact factor: 6.261

6.  The selective inhibition of nuclear PKCζ restores the effectiveness of chemotherapeutic agents in chemoresistant cells.

Authors:  Alessandro Rimessi; Erika Zecchini; Roberta Siviero; Carlotta Giorgi; Sara Leo; Rosario Rizzuto; Paolo Pinton
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

Review 7.  Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.

Authors:  Pankit Vachhani; Prithviraj Bose; Mohamed Rahmani; Steven Grant
Journal:  Physiol Genomics       Date:  2014-05-13       Impact factor: 3.107

8.  Network-based drug discovery by integrating systems biology and computational technologies.

Authors:  Elaine L Leung; Zhi-Wei Cao; Zhi-Hong Jiang; Hua Zhou; Liang Liu
Journal:  Brief Bioinform       Date:  2012-08-09       Impact factor: 11.622

Review 9.  Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

Authors:  Piet Borst
Journal:  Open Biol       Date:  2012-05       Impact factor: 6.411

10.  What does it take to synergistically combine sub-potent natural products into drug-level potent combinations?

Authors:  Chu Qin; Kai Leng Tan; Cun Long Zhang; Chun Yan Tan; Yu Zong Chen; Yu Yang Jiang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.